Resistance of THP-1 Leukemia Cells Infected with Cytomegalovirus to Anti-tumor Antibiotic Doxorubicin and Restoration of the Sensitivity by Inhibitors of the PI3K/AKT/mTOR Molecular Pathway


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

Results obtained showed that infection with HCMV prevented the death of THP-1 cells treated with DOX in both active and latent forms of infection. In the presence of mTOR inhibitors (rapamycin and Torin2), the sensitivity of the infected cells to DOX was restored. Rapamycin inhibited the expression of the HCMV protein IE1-p72 and increased sensitivity to DOX. Molecular targets for the creation of new drugs for the treatment of leukemia in patients infected with HCMV were determined.

Авторлар туралы

Ya. Chernoryzh

Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: vitallku@mail.ru
Ресей, Moscow

N. Fedorova

Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: vitallku@mail.ru
Ресей, Moscow

K. Yurlov

Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: vitallku@mail.ru
Ресей, Moscow

R. Simonov

Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: vitallku@mail.ru
Ресей, Moscow

A. Kornev

Institute of Problems of Chemical Physics, Russian Academy of Sciences

Email: vitallku@mail.ru
Ресей, Chernogolovka, Moscow oblast

D. Karpov

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences

Email: vitallku@mail.ru
Ресей, Moscow

N. Zakirova

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences

Email: vitallku@mail.ru
Ресей, Moscow

A. Ivanov

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences

Email: vitallku@mail.ru
Ресей, Moscow

A. Kushch

Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Хат алмасуға жауапты Автор.
Email: vitallku@mail.ru
Ресей, Moscow

A. Gintsburg

Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; The First Sechenov Moscow State Medical University under Ministry of Health of the Russian Federation

Email: vitallku@mail.ru
Ресей, Moscow; Moscow

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Pleiades Publishing, Inc., 2019